CVR: 36497661 Unknown
MedTrace Pharma A/S is a Danish company registered under CVR number 36497661 in Hørsholm. The company is listed as Aktieselskab and operates in Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events, with registration history from 2015. DanishCompanyCheck combines public registry data, financial filings, ownership records and compliance signals in one English company profile.
| Year | Revenue | Result | Equity | Total assets |
|---|---|---|---|---|
| 2024 | 2.334.356 kr. | -15.355.876 kr. | 270.064.727 kr. | 289.594.692 kr. |
| 2023 | 2.645.338 kr. | -15.106.505 kr. | 285.237.322 kr. | 307.595.243 kr. |
| 2022 | 2.192.838 kr. | -37.035.484 kr. | 161.190.573 kr. | 190.684.722 kr. |
| 2021 | 1.529.103 kr. | -17.851.683 kr. | 93.706.533 kr. | 119.516.000 kr. |
| 2020 | - | 1.244.338 kr. | 34.616.678 kr. | 58.519.724 kr. |
| Name | Role | Ownership |
|---|---|---|
| Peter Juul Kristensen | ADM. DIR. | - |
| Martin Dal Stenfeldt | STIFTERE | - |
| Lykke Rømer | DIREKTØR | - |
| Charlotte Vindfeldt | BESTYRELSESMEDLEM | - |
| Jens Hesthaven Sørensen | BESTYRELSESMEDLEM | - |
| SCANSYS HOLDING ApS | STIFTERE | - |
| KPMG P/S | REVISION | - |
| WIIK INVEST ApS | STIFTERE | - |
| Kapitalforeningen BankInvest Select | EJERREGISTER | 5% |
| Cesare Orlandi | BESTYRELSESMEDLEM | - |
| Fund Investments S.A. SICAV-RAIF - Verve Venture Fund I | EJERREGISTER | 5% |
| Ellen Rietmann Ahl | BESTYRELSESMEDLEM | - |
| P number | Name | Address | Industry |
|---|---|---|---|
| 1027752574 | MedTrace Pharma A/S | Agern Alle 5, 2970, Hørsholm | Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events |
| 1020087192 | MedTrace Pharma A/S | Diplomvej 381, 2800, Kongens Lyngby | Fremstilling af medicinske og dentale instrumenter samt udstyr hertil |
| 1027461065 | MedTrace Pharma A/S | Bogøvej 15, 8382, Hinnerup | Fremstilling af medicinske og dentale instrumenter samt udstyr hertil |
Use this page to verify company identity, registration status, financial history, management and ownership before trading with a Danish counterparty.